During the effector phase, activated T-cells are trafficked to specific sites by following a chemokine gradient; on contact with tumor cells, they release interferon gamma (IFN-γ) and other cytokines, promoting cytotoxicity [1,2]. This evidence concerns the gene IFNG and neoplasm.